1. Home
  2. TNGX vs PGRU Comparison

TNGX vs PGRU Comparison

Compare TNGX & PGRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • PGRU
  • Stock Information
  • Founded
  • TNGX 2014
  • PGRU 2006
  • Country
  • TNGX United States
  • PGRU Singapore
  • Employees
  • TNGX N/A
  • PGRU N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • PGRU EDP Services
  • Sector
  • TNGX Health Care
  • PGRU Technology
  • Exchange
  • TNGX Nasdaq
  • PGRU Nasdaq
  • Market Cap
  • TNGX 634.3M
  • PGRU 1.1B
  • IPO Year
  • TNGX N/A
  • PGRU N/A
  • Fundamental
  • Price
  • TNGX $5.75
  • PGRU $6.63
  • Analyst Decision
  • TNGX Strong Buy
  • PGRU Buy
  • Analyst Count
  • TNGX 8
  • PGRU 2
  • Target Price
  • TNGX $15.14
  • PGRU $7.00
  • AVG Volume (30 Days)
  • TNGX 1.0M
  • PGRU 210.6K
  • Earning Date
  • TNGX 11-06-2024
  • PGRU 11-19-2024
  • Dividend Yield
  • TNGX N/A
  • PGRU N/A
  • EPS Growth
  • TNGX N/A
  • PGRU N/A
  • EPS
  • TNGX N/A
  • PGRU N/A
  • Revenue
  • TNGX $42,509,000.00
  • PGRU $116,419,914.00
  • Revenue This Year
  • TNGX $18.15
  • PGRU $14.24
  • Revenue Next Year
  • TNGX N/A
  • PGRU $18.14
  • P/E Ratio
  • TNGX N/A
  • PGRU N/A
  • Revenue Growth
  • TNGX 26.16
  • PGRU 9.47
  • 52 Week Low
  • TNGX $5.62
  • PGRU $3.15
  • 52 Week High
  • TNGX $13.01
  • PGRU $6.65
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 31.91
  • PGRU 62.05
  • Support Level
  • TNGX $5.62
  • PGRU $6.56
  • Resistance Level
  • TNGX $6.98
  • PGRU $6.64
  • Average True Range (ATR)
  • TNGX 0.47
  • PGRU 0.02
  • MACD
  • TNGX -0.01
  • PGRU -0.01
  • Stochastic Oscillator
  • TNGX 17.89
  • PGRU 69.75

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About PGRU PropertyGuru Group Limited

PropertyGuru Group Ltd is a property technology company. The company provides digital property marketplaces to match buyers and tenants with sellers and landlords, digital marketing services for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, and property data consultancy services for banks, valuers and property developers. Their operating segments and reportable segments are each of its four marketplaces, Singapore, Vietnam, Malaysia and Other Asia, and Fintech and data services.

Share on Social Networks: